retatrutide clinical trial updates UK: 2026 & Approval Guide – Trim retatrutide clinical trials phase FDA

We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on gastrointestinal side effects in the label. In a statement to The Hill for their article Ozempic, Mounjaro manufacturers sued over risk of stomach paralysis by Julia Shapero an Eli Lilly spokesperson claimed: patient safety is the companys top priority, noting that it actively [engages] in monitoring, evaluating and reporting safety information for all of its medicines. There is something important here that Ive seen misinformation floating around about for years

We continue with periodic lab checks and body composition scans to ensure you stay on track

Kahnert K, Alter P, Welte T, et al

It is a licensed telehealth service that provides access to real, FDA-approved GLP-1 medications like semaglutide and tirzepatide